Physician profile
Suraj Sunder
NPI 1144661794
$1,770.27
in general payments reported to CMS, 2019-2025
16 companies · $691 in 2025
The $691 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $309 · 2021: $126 · 2022: $308 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354 · Travel and Lodging: $311 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.79 |
| Travel and Lodging | $311.24 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $379.88 | 2019-2020 | |
| Getinge USA Sales, LLC | $311.24 | 2025 | Vasoview Hemopro 2 |
| Actelion Pharmaceuticals US, INC. | $235.65 | 2019-2021 | |
| Inari Medical, INC. | $215.17 | 2022 | |
| Merck Sharp & Dohme LLC | $183.02 | 2019-2025 | Winrevair |
| Abiomed | $137.53 | 2025 | |
| Grifols USA, LLC | $48.72 | 2022-2025 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $46.99 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.05 | 2020-2022 | |
| Circassia INC. | $32.80 | 2019-2020 | |
| Glaxosmithkline, LLC. | $28.05 | 2022 | |
| Verona Pharma, INC. | $25.38 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.09 | 2022 | |
| Inogen, INC. | $23.57 | 2025 | |
| Mylan Specialty L.P. | $22.94 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $17.19 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suraj Sunder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.